The BIO5 Institute welcomes Gina Compitello back to the University of Arizona as its new director of communications, marketing, and public affairs, effective October 13, 2025.

Dr. Maya Kaelberer and her research group focus on understanding how the gut senses and responds to the complex composition of food.

On September 20, around 200 guests joined BIO5 for science and art activities for Wellness and Wonder Day 2025.

BIO5 member John Elfar and colleagues at the University of Arizona found that erythropoietin, a drug used for anemia, may speed healing in nerve crush injuries by boosting repair cells and clearing debris, offering a potential new treatment path

BIO5 member Todd Vanderah and University of Arizona collaborators are testing NCWR-10, a promising long-acting molecule that could reverse fentanyl overdoses with a single dose, offering a potential breakthrough in saving lives.

State-of-the-art technology and interdisciplinary expertise position the university at the forefront of imaging innovation in Arizona.

BIO5 member Jessica Rick is helping shed light on the debate over whether the Gila chub is a distinct species or part of a larger complex, a decision that could reshape conservation protections in the Southwest.

Corn rootworms are evolving resistance that threatens even the newest biotech defense combining Bt and RNA interference. BIO5 members Bruce Tabashnik and Yves Carrière found the pests adapt quickly, urging integrated pest management to protect crops and farmers.

Dr. Travis Wheeler and his research group use computational methods to advance genome research, drug discovery, and precision medicine.

BIO5 member Katharina Schimmel is advancing research on hereditary hemorrhagic telangiectasia, a genetic disease that causes dangerous blood vessel malformations. Her work aims to improve early diagnosis and uncover new treatment options.